184 related articles for article (PubMed ID: 22546819)
1. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer?
Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M
Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
3. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
[TBL] [Abstract][Full Text] [Related]
4. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
[TBL] [Abstract][Full Text] [Related]
5. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
6. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
8. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy.
Kim HJ; Kim TJ; Song T; Kim MK; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2012 May; 22(4):611-6. PubMed ID: 22398712
[TBL] [Abstract][Full Text] [Related]
10. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
11. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
[TBL] [Abstract][Full Text] [Related]
12. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.
Fang C; Zhang Y; Zhao L; Chen X; Xia L; Zhang P
BMC Cancer; 2020 Jul; 20(1):654. PubMed ID: 32660444
[TBL] [Abstract][Full Text] [Related]
13. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
14. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of lymphatic dissemination in endometrial cancer: is it adequate to perform lymph node dissection up to the inferior mesenteric artery?
Turan T; Yilmaz SS; Hizli D; Gündoğdu B; Boran N; Tulunay G; Özfuttu A; Köse MF
Int J Gynecol Cancer; 2011 Jul; 21(5):864-9. PubMed ID: 21666486
[TBL] [Abstract][Full Text] [Related]
16. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
19. Analysis of patients with stage IIIC endometrial cancer.
Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
[TBL] [Abstract][Full Text] [Related]
20. Incidence of nodal metastasis and isolated aortic metastases in patients with surgically staged endometrioid endometrial cancer.
Sautua RR; Goiri K; Calle MA; Marin IJ; Artola AL
Int J Gynecol Cancer; 2015 Jun; 25(5):875-8. PubMed ID: 25774712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
